Don't Jump to Newer Diabetes Meds for Renal Protection Yet

September 2018

You may hear about using SGLT2 inhibitors (empagliflozin, etc) or GLP-1 agonists (liraglutide, etc) for renal protection in type 2 diabetes.

We know ACE inhibitors or ARBs slow progression of nephropathy in diabetes patients with hypertension and albuminuria.

Now growing data suggest certain SGLT2 inhibitors or GLP-1 agonists may also offer renal protection...independent of blood glucose lowering.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote